TotalMarketCap

Ani Pharmaceuticals

ANIPNasdaq United StatesHealth CareBiotechnology: Pharmaceutical Preparations

Market cap

$1.598 B

$69.62 -2.83%

Close of 6 Nov 2026

As of 6 Nov 2026, Ani Pharmaceuticals (ANIP) has a market capitalization of $1.60B. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

$883.4M

#1579 by revenue

Earnings

$78.0M

#1394 by earnings

Shares outstanding

22,491,281

Latest filing cover page

P/E ratio

20.5

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →
  1. #105Generate BiomedicinesGENB$1.64B
  2. #106Nurix TherapeuticsNRIX$1.63B
  3. #107Ani PharmaceuticalsANIP$1.60B
  4. #108SELLAS Life Sciences GroupSLS$1.59B
  5. #109Ultragenyx PharmaceuticalRARE$1.58B

What if Ani Pharmaceuticals were worth as much as…

Open the what-if tool →

Gold $28.2T

$1,229,856

Per share 17,665× higher

Bitcoin $1.53T

$66,545.39

Per share 956× higher

Apple $5.02T

$218,462.30

Per share 3,138× higher

Or at a round number

$2.00B$5.00B$10.0B$20.0B

Where these numbers come from

Share counts and financials for Ani Pharmaceuticals are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.